BGI and Hummingbird Diagnostics sign memorandum of understanding
BGI, one of the world’s leading genomics organisations, headquartered in Shenzhen, Guangdong, P. R. China, and Hummingbi…
BGI, one of the world’s leading genomics organisations, headquartered in Shenzhen, Guangdong, P. R. China, and Hummingbi…
BGI, eines der weltweit führenden Unternehmen auf dem Gebiet der Genomik mit Sitz in Shenzhen, Guangdong (Volksrepublik…
The latest study results that illustrate the high potential of microRNAs (miRNAs) as biomarkers for a broad range of dis…
febit announced today the receipt of an EU patent, #EP 1 728 860B1, for its technology to synthesize minimal genomes.…
febit today announced that the company now offers whole genome sequencing services in Europe for a broad range of specie…
Ab sofort bietet die febit biomed gmbh einen Sequenzierservice für komplette Genome verschiedenster Spezies an. febit bi…
febit today announced the launch of its HybSelector, a new instrument for high throughput targeted resequencing, at the…
febit stellt in der kommenden Woche auf der 11. Konferenz "Advances in Genome Biology and Technology" (AGBT) in Florida…
Die Molecular Genetics Core Facility (MGCF) am Children's Hospital Boston (USA) hat sich für den Einsatz von febit's Hyb…
febit's HybSelect has been recognized as one of the winners of the "Top 10 Innovations of 2009" by The Scientist magazin…